Tasquinimod ( Active Biotech ) is an oral immunomodulatory , anti-angiogenic , and anti-metastatic agent that delayed metastatic disease progression in a randomized placebo-controlled phase II trial in men with metastatic castration-resistant prostate cancer ( mCRPC ) .